Aligning Access Investments to Today’s Payer Realities

Establishing market access and reimbursement for new pharmaceuticals is perhaps harder today than at any point in the industry’s history. Manufacturers can leverage rebates, price protection contracts, and copay assistance programs to achieve access goals but must make and time these investments carefully to avoid unsustainable erosion of profit that is challenging to reverse.